Döring H F, Müllejans-Kreppel U
Z Hautkr. 1987 Aug 15;62(16):1205-13.
In 1984 and 1985, 62 patients suffering from atopic dermatitis were systemically treated with chloroquine for 3 to 6 months. In 46 of the patients, the therapy resulted in significant improvement, so that all systemic or topical treatment with glucocorticoids could be discontinued. 8 patients revealed moderate improvement, which did not allow the discontinuation of topical glucocorticoids. 6 patients showed adverse reactions, which forced us to stop therapy with chloroquine. 2 patients broke off therapy because of side effects.